SRPK1 and cancer: In addition to the dysregulation of MAPK pathways in colon and breast cancers owing to activity changes in MAP2K1 and MAP2K2, SRPK1 overexpression can also affect the splicing of the MAPK signaling pathway component PYK2 which, in turn, has been associated with cancer development [115].